Almirall to co-market Pfizer's Caduet in Spain under Astucor brand

Leading Spanish pharmaceutical firm Laboratorios Almirall has agreed to co-market the cardiovascular drug Caduet (amlodipine and atorvastatin) in its home market, under the brand name Astucor, together with its originator, USA-based Pfizer. The medicine will also be marketed in Spain by the world drug giant under the trade name Caduet. The Spanish launch is anticipated for the first quarter of next year. Almirall noted that Pfizer has been commercializing the product since 2004 in the USA, France, Austria, Switzerland and Turkey, adding that the deal strengthens its product portfolio in the cardiovascular area. The single tablet reduces the risk of non-fatal myocardial infarction and fatal coronary disease by 53% in hypertensive patients at high cardiovascular risk.